海外の治験の状況「1」での検索結果
36895件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
- Neurofibromatosis Type 1;Cutaneous Neurofibromas;Neurofibromatosis Type 1;Cutaneous Neurofibromas
- United States
- 2008-03-27
Not recruiting
- Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
- Glucose Homeostasis;Glucose Homeostasis;Glucose Homeostasis;Glucose Homeostasis
- United States
- 2009-07-24
Recruiting
- Natural History Study of Patients With Neurofibromatosis Type I
- Neurofibromatosis Type 1;Malignant Peripheral Nerve Sheath Tumor;Plexiform Neurofibroma;Optic Glioma;Neurofibroma
- United States
- 2009-06-17
Not recruiting
- Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
- Diabetes
- Denmark
- 2009-04-03
Not recruiting
- Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
- Metabolic Syndrome
- Italy
- 2009-03-05
Not recruiting
- Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
- Melanoma
- Australia, India, New Zealand
- 2009-02-02
Not Recruiting
- Untersuchung des Einflusses von Carbamazepin auf die mittels transkranieller Magnetstimulation gemessene kortikale Exzitabilität des menschlichen Motorkortex in Abhängigkeit vom Polymorphismus für SCN1A Differential effect of Carbamazepine on cortical excitability in subjects with different genotypes for SCN1A as measured by transcranial magnetic stimulation (TMS) - Epicure SP5- TMS- SCN1A
- Die Studie soll zur Überprüfung folgender Hypothesen dienen: 1. Bei gesunden Probanden mit dem Genotyp AA für das SCN1A-Gen kommt es zu einem geringeren Anstieg der RMT durch Carbamazepin im Vergleich zu gesunden Probanden des Genotyps GG. 2. Die Baseline-Messung der RMT ergibt bei Probanden des Genotyps AA eine niedrigere Schwelle als bei Probanden des Genotyps GG. MedDRA version: 9.1 Level: LLT Classification code 10015037 Term: Epilepsy
- Germany
- 2009-01-20
Recruiting
- ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
- Osteosarcoma;Osteosarcoma;Osteosarcoma
- Italy
- 2011-10-19
Not recruiting
- Neurofibromatosis Type 1 Patient Registry
- Neurofibromatosis Type 1;Neurofibromatosis Type 1;Neurofibromatosis Type 1;Neurofibromatosis Type 1
- United States
- 2011-08-02
Not recruiting
- The neural basis and treatment of reading disability in children with neurofibromatosis type 1
- Neurofibromatosis type 1;Reading difficulties
- Australia
- 2011-07-26
Not recruiting
- Does exogenous glucose-dependent insulinotropic polypeptide (GIP) in combination with glucagon-like peptide-1 (GLP-1) attenuate the glycaemic response to small intestinal nutrient in critically ill patients?
- Blood Glucose
- Australia
- 2011-07-14
Not recruiting
- Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)
- Myocardial Infarction;Myocardial Infarction;Myocardial Infarction
- Denmark
- 2005-07-29
Not recruiting
- Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
- Neurofibromatosis Type I;Legius Syndrome
- United States
- 2005-05-19
Authorised
- Effect of nasal GLP-1 versus placebo on fasting state and postprandial hyperglycaemia in type 2 diabetes. A single centre, prospective, placebo controlled clinical trial evaluating efficacy and safety of nasal GLP-1 versus placebo in type 2 diabetes.
- Diabetes Mellitus type 2
- Denmark
- 2006-11-01
Not recruiting
- Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
- Neurofibromas;Neurofibromatosis Type 1
- United States
- 2006-04-11
Not recruiting
- Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
- Neurofibromatosis Type 1;Tibial Dysplasia
- United States
- 2006-03-14
Not recruiting
- A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.
- Diabetes Mellitus Type 2
- Australia, France, Germany, Mexico, Peru, Puerto Rico, Russian Federation, United States
- 2007-04-16
Not recruiting
- Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
- Diabetes;Hypoglycemia
- Australia, New Zealand, United States
- 2007-03-26
Not Recruiting
- A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK-0364) in Obese Patients Followed by a 1-Year Extension - Taranabant: 1-Yr Weight Loss Followed by 1-Yr Prevention of Weight Regain with 1-Year Extension
- Obesity MedDRA version: 7.1 Level: LLT Classification code 10029883
- Hungary, Ireland, Italy, Sweden, United Kingdom
- 2005-06-22
Not Recruiting
- EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS ON AMBULATORY BLOOD PRESSURE AND CARDIOVASCULAR FUNCTION IN HYPERTENSIVE PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS.
- Hypertension, end-stage renal disease on peritoneal dialysis
- Japan
- 2008-11-01